Actelion wants to create value in its industry and the best way is to innovate as well as discover and develop new drugs says CEO, Jean-Paul Clozel, when weighing in on potential M&A opportunities.
» Read More
Contact Biotech and Pharma
Get the best of CNBC in your inbox
Please choose a subscription
Please enter a valid email address